Xaira Therapeutics alternatives and competitors
The closest alternatives to Xaira Therapeutics are Recursion, Immunai, Deep Genomics and Eikon Therapeutics.
South San Francisco company founded in 2023 and launched publicly in April 2024 with more than $1 billion in committed funding, co led by ARCH Venture Partners and Foresite Labs.
10 alternatives to Xaira Therapeutics
What each product does, with its price as the vendor publishes it.
-
R
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
Price: Not applicable
-
I
Immunai occupies a different position from most of this category. It is not developing its own drugs.
Price: No published price
-
D
Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease.
Price: No published price
-
E
Drug discovery company built around super resolution live cell fluorescence microscopy, applying advanced optics descended from Nobel recognized single molecule imaging work together with machine learning to track how individual proteins behave and move inside living cells, rather than…
Price: Not applicable
-
I
immunitoAI designs antibody drugs with AI and tests the designs in its own laboratory.
Price: No published price
-
T
Terray Therapeutics is a Los Angeles small molecule company whose founding argument is about data rather than models. Its chief executive Jacob Berlin put it plainly at the Series A: even the most powerful artificial intelligence cannot get past insufficient or unclear data.
Price: Not applicable
-
N
Numerion Labs, formerly known as Atomwise, is a San Francisco AI drug discovery company developing small molecules for immune and inflammatory disease, led by chief executive Steve Worland.
Price: No published price
-
I
insitro is a South San Francisco AI therapeutics company founded in 2018 by Daphne Koller, built on causal biology.
Price: Not applicable
-
E
Enveda is a clinical stage biotechnology company in Boulder, Colorado that uses AI to discover medicines from the chemistry of living things.
Price: Not applicable
-
C
Cellarity is a Flagship Pioneering company in Somerville, Massachusetts, founded in 2019, that designs drugs against the behavior of a whole cell rather than against a molecular target.
Price: Not applicable
Xaira Therapeutics alternatives, answered
What are the best alternatives to Xaira Therapeutics?
The closest alternatives to Xaira Therapeutics are Recursion, Immunai, Deep Genomics, Eikon Therapeutics and immunitoAI. Immunai occupies a different position from most of this category. Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease. immunitoAI designs antibody drugs with AI and tests the designs in its own laboratory.
Who are Xaira Therapeutics's competitors?
Xaira Therapeutics's competitors in the Drug Discovery AI category include Recursion, Immunai, Deep Genomics, Eikon Therapeutics, immunitoAI and Terray Therapeutics.